Drug Allergy Market Share to Create Lucrative Prospects for Manufacturers’ Revenue By 2030

0
32

Drug allergy market outlooks and analysis by type, diagnosis, by treatment and by end user- forecast till 2030. The current report by Market Research Future (MRFR) asserts that the global drug allergy market 2023 is slated to acquire a substantial market valuation of USD 5,734.2 billion by 2030, at a moderate 6.1% CAGR over the review period.

Due to rising allergy awareness, the introduction of cutting-edge product therapies, and rising demand from emerging nations, the global market is growing. Additional study into preventing drug allergies is a crucial industry driver. Over the coming years, the market for drug allergies is anticipated to continue its modest growth.

Competitive Landscape

The top market players identified by MRFR in the global market are Bayer (US), AstraZeneca (UK), Circassia (US), Johnson & Johnson Services, Inc. (US), HAL Allergy Group (the Netherlands), Stallergenes Greer (UK), MAGNA Pharmaceuticals, Inc. (US), and others.a

Market Segmentation

The global drug allergy market is segmented on the basis of type, diagnosis, treatments, end user, and region.

on the basis of type, which comprises of nonimmunologic, immunologic, and others. Immunologic allergy is sub-segmented into type II reaction, type IV reaction, type I reaction, type III reaction, and others. The non-immunologic allergy is sub-segmented into unpredictable, predictable, and others. The predictable allergy is further segmented into secondary pharmacologic side effects, pharmacologic side effects, drug toxicity, drug overdose, drug-drug interactions, and others. The unpredictable segment is further sub-segmented into idiosyncratic, pseudoallergic, intolerance, and others.

On the basis of diagnosis, the drug allergy market is segmented into blood tests, skin tests, patch tests, and others. The skin test is further segmented into the intradermal test, prick or scratch test, and others.

On the basis of treatments, the drug allergy market is segmented into corticosteroids, antihistamines, withdrawal of the drug, treatment of anaphylaxis, and others. Antihistamines are further sub-segmented into azelastine nasal sprays, cyproheptadine, carbinoxamine, desloratadine, emedastine eyedrops, diphenhydramine, hydroxyzine, levocabastine oral, azelastine eyedrops, levocabastine eyedrops, and others. Corticosteroids is further sub-segmented into inhaled steroids, topical steroids, and others. Inhaled steroids are further segmented into flunisolide, fluticasone propionate, fluticasone furoate, triamcinolone acetonide, budesonide, beclomethasone dipropionate, and others.

On the basis of end-user, the market is segmented into medical research centers, hospitals & clinics, academic institutes, and others.

Regional Overview

The geographical overview of the global drug allergy market share has been conducted in four major regions, specifically North America, Europe, the Asia Pacific, and the rest of the world (including Latin America and the Middle East and Africa).

The Americas lead the global market for drug allergy. The Americas mainly include Latin America and North America, out of which North America accounts for the maximum market share of this region. The US is the top revenue-generating market in North America and is one of the critical markets for global drug allergy treatment. Approximately 10% of the total US population has drug allergies. Latin America’s drug allergy market is also growing significantly and mainly includes Brazil, Argentina, and Chile. Europe is the second-largest market in the globe owing to increasing cases of drug allergy.

Europe is primarily divided into Eastern Europe and Western Europe. More developed Western European countries like UK, Germany, and France are leading this market while the East European region is also rising significantly. Growing cases of drug allergies are one of the substantial factors for the progress of the European market.

Asia Pacific region is experiencing the fastest growth rate in the global drug allergy market due to some significant factors such as availability of treatment products, increasing awareness about various drug allergies, and rapidly improving healthcare facilities. Japan is holding a noteworthy market share, while China’s drug allergy market is anticipated to show the fastest growth in this region. Varying healthcare practices and growing patient involvement play a vital role in the expansion of this market.

Due to a lack of knowledge about diseases and conventional medical procedures, among other factors, it is predicted that the Middle East and Africa will experience only modest growth. Due to a number of important variables, including well-developed healthcare facilities and government assistance for enhancing public health, the Middle East leads the regional market.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: sales@marketresearchfuture.com

Website: https://www.marketresearchfuture.com